Freshfields advises Agilent Technologies, a global leader in analytical and clinical laboratory technologies, on its agreement to sell Resolution Bioscience, a company that develops and commercializes next-generation sequencing-based precision oncology solutions, to Exact Sciences Corporation. Agilent acquired Resolution Bioscience in 2021 in a transaction on which Freshfields also advised.

Further details of the transaction are available here.

The Freshfields deal team included Global Transactions partner Jonathan Zhou and senior associate Max Sanders, Intellectual Property partner Mena Kaplan, senior associate Marissa Yu and associate Jennifer Lei, Life Sciences partner Vinita Kailasanath, People and Rewards partner Sarah Ghulamhussain, and paralegals Cavika Prashad and Michael Tozzi.